Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales ...

Sanofi has reported that the high-dose formulation of its influenza vaccine, Elfueda (known as Fluzone High-Dose in the US), ...

The study demonstrated strong clinical accuracy in differentiating pancreatic cancer patients from control subjects ...

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific ...

Mission Therapeutics, a clinical-stage biotechnology company, has raised $13.3m to advance the clinical development of its ...

International Patient Engagement Day 2025 has been launched by the International Society for Patient Engagement Professionals ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...

AI in pharmaceuticals spans blue-sky possibilities to immediate practical applications delivering value today. AI-powered ...

Bristol Myers Squibb (BMS) has agreed to acquire Orbital Therapeutics in a deal valued at $1.5bn. Robert Plenge, executive VP ...

Healthcare research with the potential to improve patient outcomes is abundant; however, evidence often fails to be promptly ...

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern ...